Published on in Vol 10, No 6 (2021): June

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/24510, first published .
Directly Observed Therapy to Measure Adherence to Tuberculosis Medication in Observational Research: Protocol for a Prospective Cohort Study

Directly Observed Therapy to Measure Adherence to Tuberculosis Medication in Observational Research: Protocol for a Prospective Cohort Study

Directly Observed Therapy to Measure Adherence to Tuberculosis Medication in Observational Research: Protocol for a Prospective Cohort Study

Journals

  1. Overbeck V, Malatesta S, Carney T, Myers B, Parry C, Horsburgh C, Theron D, White L, Warren R, Jacobson K, Bouton T. Understanding the impact of pandemics on long-term medication adherence: directly observed therapy in a tuberculosis treatment cohort pre- and post-COVID-19 lockdowns. BMC Infectious Diseases 2024;24(1) View
  2. Tzelios C, Malatesta S, Carney T, White L, Weber S, Thomson S, Theron D, Myers B, Parry C, Warren R, Horsburgh C, Farhat M, Jacobson K. Patient Determinants and Effects on Adherence of Adverse Drug Reactions to Tuberculosis Treatment: A Prospective Cohort Analysis. Clinical Infectious Diseases 2025;81(1):167 View
  3. Niemand N, Rooney J, Malatesta S, Rawoot N, Bouton T, Ragan E, Carney T, White L, Farhat M, Horsburgh C, Myers B, Warren R, Jacobson K, Warren B. Contamination rates in serially sampled sputum specimens obtained during tuberculosis treatment to capture culture conversion. Microbiology Spectrum 2025;13(10) View